Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology

Journal of Molecular and Cellular Cardiology

Volumn 77, Issue , 2014, Pages 178-191

  Hayakawa, Tomohiro ^a   Kunihiro, Takeshi ^a   Ando, Tomoko ^b   Kobayashi, Seiji ^a   Matsui, Eriko ^a   Yada, Hiroaki ^a   Kanda, Yasunari ^b   Kurokawa, Junko ^b   Furukawa, Tetsushi ^b  

^a SONY CORPORATION   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Ca2+ transient; Field potential; Human induced pluripotent stem cell derived cardiomyocytes; Motion vector prediction; Multi electrode arrays; Traction force microscopy

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; CALCIUM ION; ISOPRENALINE; SODIUM; TETRODOTOXIN; VERAPAMIL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; PIPERIDINE DERIVATIVE; PYRIDINE DERIVATIVE; SODIUM CHANNEL BLOCKING AGENT;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC POTENTIAL; FLUORESCENCE ANALYSIS; HEART CONTRACTION; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE RELAXATION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MICROSCOPY; MOLECULAR IMAGING; PLURIPOTENT STEM CELL; SODIUM CURRENT; TRACTION FORCE MICROSCOPY; VIDEO MICROSCOPY; BIOMECHANICS; CALCIUM SIGNALING; CELL CULTURE; CELL DIFFERENTIATION; DRUG EFFECTS; HEART FUNCTION TEST; KINETICS; PHYSIOLOGY;

ADRENERGIC BETA-AGONISTS; BIOMECHANICAL PHENOMENA; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELLS, CULTURED; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ISOPROTERENOL; KINETICS; MICROSCOPY, VIDEO; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PIPERIDINES; PYRIDINES; SODIUM CHANNEL BLOCKERS; TETRODOTOXIN; VERAPAMIL;

EID: 84910000985     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.09.010     Document Type: Article

References (80)

1. Habib M., Caspi O., Gepstein L. Human embryonic stem cells for cardiomyogenesis. J Mol Cell Cardiol Oct 2008, 45(4):462-474.
2. Caspi O., Itzhaki I., Kehat I., Gepstein A., Arbel G., Huber I., et al. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev Jan-Feb 2009, 18(1):161-172.
3. Tanaka T., Tohyama S., Murata M., Nomura F., Kaneko T., Chen H., et al. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun Aug 7 2009, 385(4):497-502.
4. Guo L., Abrams R.M., Babiarz J.E., Cohen J.D., Kameoka S., Sanders M.J., et al. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci Sep 2011, 123(1):281-289.
5. Kadota S., Minami I., Morone N., Heuser J.E., Agladze K., Nakatsuji N. Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets. Eur Heart J Apr 2013, 34(15):1147-1156.
6. Nakamura Y., Matsuo J., Miyamoto N., Ojima A., Ando K., Kanda Y., et al. Assessment of testing methods for drug-induced repolarization delay and arrhythmias in an iPS cell-derived cardiomyocyte sheet: multi-site validation study. J Pharmacol Sci 2014, 124(4):494-501.
7. Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Habib I.H., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res Feb 2 2007, 100(2):263-272.
8. Yoshida Y., Yamanaka S. iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol Feb 2011, 50(2):327-332.
9. Kawamura M., Miyagawa S., Fukushima S., Saito A., Miki K., Ito E., et al. Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart. Circulation Sep 10 2013, 128(11 Suppl. 1):S87-S94.
10. Sawa Y., Miyagawa S. Present and future perspectives on cell sheet-based myocardial regeneration therapy. BioMed Res Int 2013, 2013:583912.
11. Matsuura K., Haraguchi Y., Shimizu T., Okano T. Cell sheet transplantation for heart tissue repair. J Control Release Aug 10 2013, 169(3):336-340.
12. Itzhaki I., Schiller J., Beyar R., Satin J., Gepstein L. Calcium handling in embryonic stem cell-derived cardiac myocytes: of mice and men. Ann N Y Acad Sci Oct 2006, 1080:207-215.
13. Satin J., Itzhaki I., Rapoport S., Schroder E.A., Izu L., Arbel G., et al. Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells Aug 2008, 26(8):1961-1972.
14. Zwi L., Caspi O., Arbel G., Huber I., Gepstein A., Park I.H., et al. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation Oct 13 2009, 120(15):1513-1523.
15. Itzhaki I., Rapoport S., Huber I., Mizrahi I., Zwi-Dantsis L., Arbel G., et al. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS One 2011, 6(4):e18037.
16. Lee Y.K., Ng K.M., Lai W.H., Chan Y.C., Lau Y.M., Lian Q., et al. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Rev Nov 2011, 7(4):976-986.
17. Jonsson M.K., Vos M.A., Mirams G.R., Duker G., Sartipy P., de Boer T.P., et al. Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. J Mol Cell Cardiol May 2012, 52(5):998-1008.
18. Zhang G.Q., Wei H., Lu J., Wong P., Shim W. Identification and characterization of calcium sparks in cardiomyocytes derived from human induced pluripotent stem cells. PLoS One 2013, 8(2):e55266.
19. Sirenko O., Crittenden C., Callamaras N., Hesley J., Chen Y.W., Funes C., et al. Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells. J Biomol Screen Jan 2013, 18(1):39-53.
20. Navarrete E.G., Liang P., Lan F., Sanchez-Freire V., Simmons C., Gong T., et al. Screening drug-induced arrhythmia events using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. Circulation Sep 10 2013, 128(11 Suppl. 1):S3-S13.
21. Xi J., Khalil M., Shishechian N., Hannes T., Pfannkuche K., Liang H., et al. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells. FASEB J Aug 2010, 24(8):2739-2751.
22. Hansen A., Eder A., Bonstrup M., Flato M., Mewe M., Schaaf S., et al. Development of a drug screening platform based on engineered heart tissue. Circ Res Jul 9 2010, 107(1):35-44.
23. Liau B., Christoforou N., Leong K.W., Bursac N. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials Dec 2011, 32(35):9180-9187.
24. Schaaf S., Shibamiya A., Mewe M., Eder A., Stohr A., Hirt M.N., et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 2011, 6(10):e26397.
25. Tulloch N.L., Muskheli V., Razumova M.V., Korte F.S., Regnier M., Hauch K.D., et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res Jun 24 2011, 109(1):47-59.
26. Hazeltine L.B., Simmons C.S., Salick M.R., Lian X., Badur M.G., Han W., et al. Effects of substrate mechanics on contractility of cardiomyocytes generated from human pluripotent stem cells. Int J Cell Biol 2012, 2012:508294.
27. Liu J., Sun N., Bruce M.A., Wu J.C., Butte M.J. Atomic force mechanobiology of pluripotent stem cell-derived cardiomyocytes. PLoS One 2012, 7(5):e37559.
28. Pillekamp F., Haustein M., Khalil M., Emmelheinz M., Nazzal R., Adelmann R., et al. Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy. Stem Cells Dev Aug 10 2012, 21(12):2111-2121.
29. Turnbull I.C., Karakikes I., Serrao G.W., Backeris P., Lee J.J., Xie C., et al. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J Feb 2014, 28(2):644-654.
30. Sun N., Yazawa M., Liu J., Han L., Sanchez-Freire V., Abilez O.J., et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med Apr 18 2012, 4(130):130ra47.
31. Tameyasu T., Toyoki T., Sugi H. Nonsteady motion in unloaded contractions of single frog cardiac cells. Biophys J Sep 1985, 48(3):461-465.
32. 2+ and contraction in single cardiomyocytes. Am J Physiol Jul 1990, 259(1 Pt 2):H230-H242.
33. Pollack P.S., Carson N.L., Nuss H.B., Marino T.A., Houser S.R. Mechanical properties of adult feline ventricular myocytes in culture. Am J Physiol Jan 1991, 260(1 Pt 2):H234-H241.
34. Mukherjee R., Crawford F.A., Hewett K.W., Spinale F.G. Cell and sarcomere contractile performance from the same cardiocyte using video microscopy. J Appl Physiol Apr 1993, 74(4):2023-2033.
35. Stummann T.C., Wronski M., Sobanski T., Kumpfmueller B., Hareng L., Bremer S., et al. Digital movie analysis for quantification of beating frequencies, chronotropic effects, and beating areas in cardiomyocyte cultures. Assay Drug Dev Technol Jun 2008, 6(3):375-385.
36. Kamgoue A., Ohayon J., Usson Y., Riou L., Tracqui P. Quantification of cardiomyocyte contraction based on image correlation analysis. Cytometry A Apr 2009, 75(4):298-308.
37. Bazan C., Barba D.T., Blomgren P., Paolini P. Image processing techniques for assessing contractility in isolated adult cardiac myocytes. Int J Biomed imaging 2009, 2009:352954.
38. Bazan C., Torres Barba D., Blomgren P., Paolini P. Image processing techniques for assessing contractility in isolated neonatal cardiac myocytes. Int J Biomed imaging 2011, 2011:729732.
39. Hossain M.M., Shimizu E., Saito M., Rao S.R., Yamaguchi Y., Tamiya E. Non-invasive characterization of mouse embryonic stem cell derived cardiomyocytes based on the intensity variation in digital beating video. Analyst Jul 2010, 135(7):1624-1630.
40. Harmer A.R., Abi-Gerges N., Morton M.J., Pullen G.F., Valentin J.P., Pollard C.E. Validation of an in vitro contractility assay using canine ventricular myocytes. Toxicol Appl Pharmacol Apr 15 2012, 260(2):162-172.
41. Harding S.E., Vescovo G., Kirby M., Jones S.M., Gurden J., Poole-Wilson P.A. Contractile responses of isolated adult rat and rabbit cardiac myocytes to isoproterenol and calcium. J Mol Cell Cardiol Jul 1988, 20(7):635-647.
42. Vescovo G., Harding S.E., Jones S.M., Dalla Libera L., Pessina A.C., Poole-Wilson P.A. Comparison between isomyosin pattern and contractility of right ventricular myocytes isolated from rats with right cardiac hypertrophy. Basic Res Cardiol Sep-Oct 1989, 84(5):536-543.
43. Steadman B.W., Moore K.B., Spitzer K.W., Bridge J.H. A video system for measuring motion in contracting heart cells. IEEE Trans Biomed Eng Apr 1988, 35(4):264-272.
44. He J.Q., Ma Y., Lee Y., Thomson J.A., Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res Jul 11 2003, 93(1):32-39.
45. Brito-Martins M., Harding S.E. Ali NN. beta(1)- and beta(2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart. Br J Pharmacol Feb 2008, 153(4):751-759.
46. Ahola A., Kiviaho A.L., Larsson K., Honkanen M., Aalto-Setala K., Hyttinen J. Video image-based analysis of single human induced pluripotent stem cell derived cardiomyocyte beating dynamics using digital image correlation. Biomed Eng Online 2014, 13(1):39.
47. Hayakawa T., Kunihiro T., Dowaki S., Uno H., Matsui E., Uchida M., et al. Noninvasive evaluation of contractile behavior of cardiomyocyte monolayers based on motion vector analysis. Tissue Eng Part C Methods Jan 2012, 18(1):21-32.
48. Ma J., Guo L., Fiene S.J., Anson B.D., Thomson J.A., Kamp T.J., et al. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am J Physiol Nov 2011, 301(5):H2006-H2017.
49. Ghanbari M. The cross-search algorithm for motion estimation. Trans Commun 1990, 38(7):950-953.
50. Dembo M., Wang Y.L. Stresses at the cell-to-substrate interface during locomotion of fibroblasts. Biophys J Apr 1999, 76(4):2307-2316.
51. Sabass B., Gardel M.L., Waterman C.M., Schwarz U.S. High resolution traction force microscopy based on experimental and computational advances. Biophys J Jan 1 2008, 94(1):207-220.
52. Tseng Q., Duchemin-Pelletier E., Deshiere A., Balland M., Guillou H., Filhol O., et al. Spatial organization of the extracellular matrix regulates cell-cell junction positioning. Proc Natl Acad Sci U S A Jan 31 2012, 109(5):1506-1511.
53. Butler J.P., Tolic-Norrelykke I.M., Fabry B., Fredberg J.J. Traction fields, moments, and strain energy that cells exert on their surroundings. Am J Physiol Cell Physiol Mar 2002, 282(3):C595-C605.
54. Yamazaki K., Hihara T., Taniguchi T., Kohmura N., Yoshinaga T., Ito M., et al. A novel method of selecting human embryonic stem cell-derived cardiomyocyte clusters for assessment of potential to influence QT interval. Toxicol In Vitro Mar 2012, 26(2):335-342.
55. Halbach M., Egert U., Hescheler J., Banach K. Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures. Cell Physiol Biochem 2003, 13(5):271-284.
56. Meyer T., Boven K.H., Gunther E., Fejtl M. Micro-electrode arrays in cardiac safety pharmacology: a novel tool to study QT interval prolongation. Drug Saf 2004, 27(11):763-772.
57. Egert U., Meyer T. Heart on a chip - extracellular multielectrode recordings from cardiomyocytes in vitro 2005.
58. Reppel M., Igelmund P., Egert U., Juchelka F., Hescheler J., Drobinskaya I. Effect of cardioactive drugs on action potential generation and propagation in embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem 2007, 19(5-6):213-224.
59. Liang H., Matzkies M., Schunkert H., Tang M., Bonnemeier H., Hescheler J., et al. Human and murine embryonic stem cell-derived cardiomyocytes serve together as a valuable model for drug safety screening. Cell Physiol Biochem 2010, 25(4-5):459-466.
60. Matsa E., Rajamohan D., Dick E., Young L., Mellor I., Staniforth A., et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur Heart J Apr 2011, 32(8):952-962.
61. Braam S.R., Tertoolen L., van de Stolpe A., Meyer T., Passier R., Mummery C.L. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res Mar 2009, 4(2):107-116.
62. Nomura F., Kaneko T., Hattori A., Yasuda K. On-chip constructive cell-network study (II): on-chip quasi-in vivo cardiac toxicity assay for ventricular tachycardia/fibrillation measurement using ring-shaped closed circuit microelectrode with lined-up cardiomyocyte cell network. J Nanobiotechnol 2011, 9:39.
63. 2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovasc Res Jan 15 2008, 77(2):265-273.
64. Borlaug B.A., Kass D.A. Mechanisms of diastolic dysfunction in heart failure. Trends Cardiovasc Med Nov 2006, 16(8):273-279.
65. Uesugi M., Ojima A., Taniguchi T., Miyamoto N., Sawada K. Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes. J Pharmacol Toxicol Methods 2014, 69(2):177-188.
66. Shinozawa T., Imahashi K., Sawada H., Furukawa H., Takami K. Determination of appropriate stage of human-induced pluripotent stem cell-derived cardiomyocytes for drug screening and pharmacological evaluation in vitro. J Biomol Screen Oct 2012, 17(9):1192-1203.
67. Bird S.D., Doevendans P.A., van Rooijen M.A., Brutel de la Riviere A., Hassink R.J., Passier R., et al. The human adult cardiomyocyte phenotype. Cardiovasc Res May 1 2003, 58(2):423-434.
68. Bhana B., Iyer R.K., Chen W.L., Zhao R., Sider K.L., Likhitpanichkul M., et al. Influence of substrate stiffness on the phenotype of heart cells. Biotechnol Bioeng Apr 15 2010, 105(6):1148-1160.
69. Hersch N., Wolters B., Dreissen G., Springer R., Kirchgessner N., Merkel R., et al. The constant beat: cardiomyocytes adapt their forces by equal contraction upon environmental stiffening. Biol Open Mar 15 2013, 2(3):351-361.
70. Wang J.H., Lin J.S. Cell traction force and measurement methods. Biomech Model Mechanobiol Nov 2007, 6(6):361-371.
71. Langer G.A., Brady A.J., Tan S.T., Serena D. Correlation of the glycoside response, the force staircase, and the action potential configuration in the neonatal rat heart. Circ Res Jun 1975, 36(6):744-752.
72. Zhang J., Wilson G.F., Soerens A.G., Koonce C.H., Yu J., Palecek S.P., et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res Feb 27 2009, 104(4):e30-e41.
73. Honda M., Kiyokawa J., Tabo M., Inoue T. Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells. J Pharmacol Sci 2011, 117(3):149-159.
74. van der Linde H.J., Van Deuren B., Somers Y., Loenders B., Towart R., Gallacher D.J. The electro-mechanical window: a risk marker for Torsade de Pointes in a canine model of drug induced arrhythmias. Br J Pharmacol Dec 2010, 161(7):1444-1454.
75. Guns P.J., Johnson D.M., Van Op den Bosch J., Weltens E., Lissens J. The electro-mechanical window in anaesthetized guinea pigs: a new marker in screening for Torsade de Pointes risk. Br J Pharmacol May 2012, 166(2):689-701.
76. Guns P.J., Johnson D.M., Weltens E., Lissens J. Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig. J Pharmacol Toxicol Methods Sep 2012, 66(2):125-134.
77. Doss M.X., Di Diego J.M., Goodrow R.J., Wu Y., Cordeiro J.M., Nesterenko V.V., et al. Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I(Kr). PLoS One 2012, 7(7):e40288.
78. Wellens H.J., Tan S.L., Bar F.W., Duren D.R., Lie K.I., Dohmen H.M. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. Br Heart J Oct 1977, 39(10):1058-1066.
79. Gay R., Algeo S., Lee R., Olajos M., Morkin E., Goldman S. Treatment of verapamil toxicity in intact dogs. J Clin Invest Jun 1986, 77(6):1805-1811.
80. Nazzaro P., Manzari M., Merlo M., Triggiani R., Scarano A.M., Lasciarrea A., et al. Antihypertensive treatment with verapamil and amlodipine. Their effect on the functional autonomic and cardiovascular stress responses. Eur Heart J Sep 1995, 16(9):1277-1284.